The antibiotics we used included meropenem (Hanhui Pharmaceutical Co., Ltd., China), imipenem (Merck Sharp & Dohme Corp., USA), cefepime (Jiangsu Hengrui Pharmaceutical Co., Ltd., China), piperacillin (Suzhou Erye Pharmaceutical Co., Ltd., China), ceftazidime (Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., China), tazobactam (Meilunbio, China), avibactam (MedChemExpress, USA), aztreonam (Sigma-Aldrich, USA), amikacin (Meilunbio), cefuroxime (Esseti Farmaceutici S.r.l., Italy), fosfomycin (Harbin Pharmaceutical Group Co., Ltd. China), levofloxacin (Daiichi Sankyo Company Limited, Beijing, China), and cefotaxime (North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd., China).
Tazobactam
Tazobactam is a beta-lactamase inhibitor. It is used in combination with certain antibiotics to enhance their effectiveness against bacteria that produce beta-lactamase enzymes.
Lab products found in correlation
3 protocols using tazobactam
Antimicrobial Susceptibility Testing of E. coli and K. pneumoniae
The antibiotics we used included meropenem (Hanhui Pharmaceutical Co., Ltd., China), imipenem (Merck Sharp & Dohme Corp., USA), cefepime (Jiangsu Hengrui Pharmaceutical Co., Ltd., China), piperacillin (Suzhou Erye Pharmaceutical Co., Ltd., China), ceftazidime (Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., China), tazobactam (Meilunbio, China), avibactam (MedChemExpress, USA), aztreonam (Sigma-Aldrich, USA), amikacin (Meilunbio), cefuroxime (Esseti Farmaceutici S.r.l., Italy), fosfomycin (Harbin Pharmaceutical Group Co., Ltd. China), levofloxacin (Daiichi Sankyo Company Limited, Beijing, China), and cefotaxime (North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd., China).
Characterization of ESBL-producing Klebsiella
Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!